CIK 0001858848
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Tenaya Therapeutics, Inc.
Sign in to watch- Ticker
- TNYA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813789973
- Phone
- +1 415-865-2066
- Business address
- 171 OYSTER POINT BLVD., SUITE 500, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-08-03 | COLUMN GROUP III GP, LP 10% owner | Conversion · Series A Preferred Stock | −3,727,742 | 0 | ||
| 2021-08-03 | COLUMN GROUP III GP, LP 10% owner | Conversion · Series A Preferred Stock | −4,209,755 | 0 | ||
| 2021-08-03 | COLUMN GROUP III GP, LP 10% owner | Conversion · Series B Preferred Stock | −472,659 | 0 | ||
| 2021-08-03 | COLUMN GROUP III GP, LP 10% owner | Conversion · Series B Preferred Stock | −533,781 | 0 | ||
| 2021-08-03 | COLUMN GROUP III GP, LP 10% owner | Conversion · Series C Preferred Stock | −188,881 | 0 | ||
| 2021-08-03 | COLUMN GROUP III GP, LP 10% owner | Conversion · Series C Preferred Stock | −213,306 | 0 | ||
| 2021-08-03 | Casdin Partners Master Fund, L.P. 10% owner | Conversion | +2,374,849 | 2,374,849 | ||
| 2021-08-03 | Casdin Partners Master Fund, L.P. 10% owner | Purchase | +850,000 | $15.00 | $12.8M | 3,224,849 |
| 2021-08-03 | Casdin Partners Master Fund, L.P. 10% owner | Conversion | +361,969 | 361,969 | ||
| 2021-08-03 | Casdin Partners Master Fund, L.P. 10% owner | Conversion · Series B Preferred Stock | −2,012,880 | 0 | ||
| 2021-08-03 | Casdin Partners Master Fund, L.P. 10% owner | Conversion · Series C Preferred Stock | −361,969 | 0 | ||
| 2021-08-03 | Casdin Partners Master Fund, L.P. 10% owner | Conversion · Series C Preferred Stock | −361,969 | 0 | ||
| 2021-08-03 | Casdin Eli Director | Conversion | +2,374,849 | 2,374,849 | ||
| 2021-08-03 | Casdin Eli Director | Purchase | +850,000 | $15.00 | $12.8M | 3,224,849 |
| 2021-08-03 | Casdin Eli Director | Conversion | +361,969 | 361,969 | ||
| 2021-08-03 | Casdin Eli Director | Conversion · Series B Preferred Stock | −2,012,880 | 0 | ||
| 2021-08-03 | Casdin Eli Director | Conversion · Series C Preferred Stock | −361,969 | 0 | ||
| 2021-08-03 | Casdin Eli Director | Conversion · Series C Preferred Stock | −361,969 | 0 | ||
| 2021-08-03 | GOEDDEL DAVID V Director | Conversion | +4,389,282 | 4,414,720 | ||
| 2021-08-03 | GOEDDEL DAVID V Director | Conversion | +4,956,842 | 4,985,570 |
Page 11 of 12 · 228 trades